Sort
261,768 grants matching “gene therapy”
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$903,535Mark Hatherill · University Of Cape Town · R01 · FY2020 · AI
Measuring cellular senescence to predict and prevent peripheral neuropathy
$903,506Natalia Mitin · Sapere Bio, Inc. · R44 · FY2022 · AG
Transcriptional condensates, epigenetic editing and Rett Syndrome
$903,497Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2021 · MH
Molecular Diagnostics Core Laboratory
$903,497Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Mutations of Chromatin and its Modifying Machineries in Malignancies
$903,468Ali Shilatifard · Northwestern University At Chicago · R35 · FY2024 · CA
A New Target for Chromatin Remodeler Defects in Cancer
$903,450Cheryl L Walker · Baylor College Of Medicine · R35 · FY2024 · CA
HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
$903,410Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P01 · FY2012 · MH
Novel Dopamine D3/D2 Receptor Ligands
$903,355Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2021 · DA
Myocardial Repair by Targeted Stem Cells
$903,306James W Larrick · Panorama Research, Inc. · R44 · FY2008 · HL
Collaborative Expansion of Marmoset Colonies for Neuroscience Research
$903,258Jon E Levine · University Of Wisconsin-Madison · U24 · FY2022 · MH
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
$903,157Susana T Valente · University Of Florida · R01 · FY2023 · AI
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$903,133Daniel E Kahne · Harvard Medical School · U19 · FY2016 · AI
Preclinical Studies of Novel Anti-Diabetic Lipids
$903,077Barbara B Kahn · Beth Israel Deaconess Medical Center · R56 · FY2017 · DK
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DA
Regulatory T Cells in Autoimmune Disease
$903,038David A. Hafler · Brigham And Women'S Hospital · U19 · FY2007 · AI
National Gene Vector Biorepository and Coordinating Center at Indiana University
$903,034Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2012 · HL
Clinical Development of Novel Drugs for Children with Refractory Cancers
$903,024Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES
$902,972Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders
$902,914Cynthia Tifft · National Human Genome Research Institute · ZIA · FY2025 · HG
Therapeutic Targeting of Malignant Glioma Stem Cells
$902,878Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2018 · CA
The Development of the Domestic Cat, Felis catus, as an Animal Model for Genetic
$902,856Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Informative Clinical Studies in Asthma
$902,817Brigham And Women'S Hospital · U10 · FY2004 · HL
Genome instability in cancer: telomeres and DNA repair
$902,733Titia De Lange · Rockefeller University · R35 · FY2016 · CA
Targeting protein secretion in Mycobacterium tuberculosis
$902,701Tanya Parish · Seattle Children'S Hospital · R01 · FY2024 · AI